Preimplantation Genetic Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030


Report
300 Pages
January 2024
Region: Global
Infinium Global Research
ID: 5933660

The report on the global preimplantation genetic testing market provides qualitative and quantitative analysis for the period from 2021-2030. The global preimplantation genetic testing market was valued at USD 769.8 million in 2022 and is expected to reach USD 1,325 million in 2030, with a CAGR of 7.04% during the forecast period 2023-2030. The study on preimplantation genetic testing market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on preimplantation genetic testing market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global preimplantation genetic testing market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global preimplantation genetic testing market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

The rising prevalence of genetic disorders is driving the growth of the market.
Decreasing female fertility with age is expected to stimulate the growth of the market.

2) Restraints

The high cost of preimplantation genetic testing can hamper the growth of the market.

3) Opportunities

Improving healthcare infrastructure and the rising medical tourism in emerging countries provide lucrative opportunities for the growth of the market.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global preimplantation genetic testing market is segmented on the basis of technology, procedure type, application, and end user.

The Global Preimplantation Genetic Testing Market by Technology

Single-nucleotide Polymorphism
Next-generation Sequencing
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Polymerase Chain Reaction

The Global Preimplantation Genetic Testing Market by Procedure Type

Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

The Global Preimplantation Genetic Testing Market by Application

Single Gene Disorders
HLA Typing
Structural Chromosomal Abnormalities
Translocations
Deletions
Duplications
Inversions
X-linked Disorders
Aneuploidy
Gender Identification

The Global Preimplantation Genetic Testing Market by End User

Fertility Clinics
Hospitals
Diagnostics Laboratories
Others

Company Profiles

The companies covered in the report include

Revvity
Thermo Fisher Scientific Inc
Abbott
Agilent Technologies, Inc.
Oxford Gene Technology IP Limited
Quest Diagnostics Incorporated
Natera, Inc.
A CooperSurgical Fertility Company
Genea Pty Limited
Illumina, Inc.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the preimplantation genetic testing market.
2. Complete coverage of all the segments in the preimplantation genetic testing market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global preimplantation genetic testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Chapter 1. Preface

1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Preimplantation Genetic Testing Market Highlights
2.2. Preimplantation Genetic Testing Market Projection
2.3. Preimplantation Genetic Testing Market Regional Highlights

Chapter 3. Global Preimplantation Genetic Testing Market Overview

3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Technology
3.4.2. Growth Matrix Analysis by Procedure Type
3.4.3. Growth Matrix Analysis by Application
3.4.4. Growth Matrix Analysis by End User
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Preimplantation Genetic Testing Market

Chapter 4. Preimplantation Genetic Testing Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Preimplantation Genetic Testing Market
5.2. Companies Profiles
5.2.1. Revvity
5.2.2. Thermo Fisher Scientific Inc
5.2.3. Abbott
5.2.4. Agilent Technologies, Inc.
5.2.5. Oxford Gene Technology IP Limited
5.2.6. Quest Diagnostics Incorporated
5.2.7. Natera, Inc.
5.2.8. A CooperSurgical Fertility Company
5.2.9. Genea Pty Limited
5.2.10. Illumina, Inc.

Chapter 6. Global Preimplantation Genetic Testing Market by Technology

6.1. Single-nucleotide Polymorphism
6.2. Next-generation Sequencing
6.3. Fluorescence in Situ Hybridization
6.4. Comparative Genomic Hybridization
6.5. Polymerase Chain Reaction

Chapter 7. Global Preimplantation Genetic Testing Market by Procedure Type

7.1. Preimplantation Genetic Screening
7.2. Preimplantation Genetic Diagnosis

Chapter 8. Global Preimplantation Genetic Testing Market by Application

8.1. Single Gene Disorders
8.2. HLA Typing
8.3. Structural Chromosomal Abnormalities
8.3.1. Translocations
8.3.2. Deletions
8.3.3. Duplications
8.3.4. Inversions
8.4. X-linked Disorders
8.5. Aneuploidy
8.6. Gender Identification

Chapter 9. Global Preimplantation Genetic Testing Market by End User

9.1. Fertility Clinics
9.2. Hospitals
9.3. Diagnostics Laboratories
9.4. Others

Chapter 10. Global Preimplantation Genetic Testing Market by Region 2023-2030

10.1. North America
10.1.1. North America Preimplantation Genetic Testing Market by Technology
10.1.2. North America Preimplantation Genetic Testing Market by Procedure Type
10.1.3. North America Preimplantation Genetic Testing Market by Application
10.1.4. North America Preimplantation Genetic Testing Market by End User
10.1.5. North America Preimplantation Genetic Testing Market by Country
10.1.5.1. The U.S. Preimplantation Genetic Testing Market
10.1.5.1.1. The U.S. Preimplantation Genetic Testing Market by Technology
10.1.5.1.2. The U.S. Preimplantation Genetic Testing Market by Procedure Type
10.1.5.1.3. The U.S. Preimplantation Genetic Testing Market by Application
10.1.5.1.4. The U.S. Preimplantation Genetic Testing Market by End User
10.1.5.2. Canada Preimplantation Genetic Testing Market
10.1.5.2.1. Canada Preimplantation Genetic Testing Market by Technology
10.1.5.2.2. Canada Preimplantation Genetic Testing Market by Procedure Type
10.1.5.2.3. Canada Preimplantation Genetic Testing Market by Application
10.1.5.2.4. Canada Preimplantation Genetic Testing Market by End User
10.1.5.3. Mexico Preimplantation Genetic Testing Market
10.1.5.3.1. Mexico Preimplantation Genetic Testing Market by Technology
10.1.5.3.2. Mexico Preimplantation Genetic Testing Market by Procedure Type
10.1.5.3.3. Mexico Preimplantation Genetic Testing Market by Application
10.1.5.3.4. Mexico Preimplantation Genetic Testing Market by End User
10.2. Europe
10.2.1. Europe Preimplantation Genetic Testing Market by Technology
10.2.2. Europe Preimplantation Genetic Testing Market by Procedure Type
10.2.3. Europe Preimplantation Genetic Testing Market by Application
10.2.4. Europe Preimplantation Genetic Testing Market by End User
10.2.5. Europe Preimplantation Genetic Testing Market by Country
10.2.5.1. Germany Preimplantation Genetic Testing Market
10.2.5.1.1. Germany Preimplantation Genetic Testing Market by Technology
10.2.5.1.2. Germany Preimplantation Genetic Testing Market by Procedure Type
10.2.5.1.3. Germany Preimplantation Genetic Testing Market by Application
10.2.5.1.4. Germany Preimplantation Genetic Testing Market by End User
10.2.5.2. United Kingdom Preimplantation Genetic Testing Market
10.2.5.2.1. United Kingdom Preimplantation Genetic Testing Market by Technology
10.2.5.2.2. United Kingdom Preimplantation Genetic Testing Market by Procedure Type
10.2.5.2.3. United Kingdom Preimplantation Genetic Testing Market by Application
10.2.5.2.4. United Kingdom Preimplantation Genetic Testing Market by End User
10.2.5.3. France Preimplantation Genetic Testing Market
10.2.5.3.1. France Preimplantation Genetic Testing Market by Technology
10.2.5.3.2. France Preimplantation Genetic Testing Market by Procedure Type
10.2.5.3.3. France Preimplantation Genetic Testing Market by Application
10.2.5.3.4. France Preimplantation Genetic Testing Market by End User
10.2.5.4. Italy Preimplantation Genetic Testing Market
10.2.5.4.1. Italy Preimplantation Genetic Testing Market by Technology
10.2.5.4.2. Italy Preimplantation Genetic Testing Market by Procedure Type
10.2.5.4.3. Italy Preimplantation Genetic Testing Market by Application
10.2.5.4.4. Italy Preimplantation Genetic Testing Market by End User
10.2.5.5. Rest of Europe Preimplantation Genetic Testing Market
10.2.5.5.1. Rest of Europe Preimplantation Genetic Testing Market by Technology
10.2.5.5.2. Rest of Europe Preimplantation Genetic Testing Market by Procedure Type
10.2.5.5.3. Rest of Europe Preimplantation Genetic Testing Market by Application
10.2.5.5.4. Rest of Europe Preimplantation Genetic Testing Market by End User
10.3. Asia Pacific
10.3.1. Asia Pacific Preimplantation Genetic Testing Market by Technology
10.3.2. Asia Pacific Preimplantation Genetic Testing Market by Procedure Type
10.3.3. Asia Pacific Preimplantation Genetic Testing Market by Application
10.3.4. Asia Pacific Preimplantation Genetic Testing Market by End User
10.3.5. Asia Pacific Preimplantation Genetic Testing Market by Country
10.3.5.1. China Preimplantation Genetic Testing Market
10.3.5.1.1. China Preimplantation Genetic Testing Market by Technology
10.3.5.1.2. China Preimplantation Genetic Testing Market by Procedure Type
10.3.5.1.3. China Preimplantation Genetic Testing Market by Application
10.3.5.1.4. China Preimplantation Genetic Testing Market by End User
10.3.5.2. Japan Preimplantation Genetic Testing Market
10.3.5.2.1. Japan Preimplantation Genetic Testing Market by Technology
10.3.5.2.2. Japan Preimplantation Genetic Testing Market by Procedure Type
10.3.5.2.3. Japan Preimplantation Genetic Testing Market by Application
10.3.5.2.4. Japan Preimplantation Genetic Testing Market by End User
10.3.5.3. India Preimplantation Genetic Testing Market
10.3.5.3.1. India Preimplantation Genetic Testing Market by Technology
10.3.5.3.2. India Preimplantation Genetic Testing Market by Procedure Type
10.3.5.3.3. India Preimplantation Genetic Testing Market by Application
10.3.5.3.4. India Preimplantation Genetic Testing Market by End User
10.3.5.4. South Korea Preimplantation Genetic Testing Market
10.3.5.4.1. South Korea Preimplantation Genetic Testing Market by Technology
10.3.5.4.2. South Korea Preimplantation Genetic Testing Market by Procedure Type
10.3.5.4.3. South Korea Preimplantation Genetic Testing Market by Application
10.3.5.4.4. South Korea Preimplantation Genetic Testing Market by End User
10.3.5.5. Australia Preimplantation Genetic Testing Market
10.3.5.5.1. Australia Preimplantation Genetic Testing Market by Technology
10.3.5.5.2. Australia Preimplantation Genetic Testing Market by Procedure Type
10.3.5.5.3. Australia Preimplantation Genetic Testing Market by Application
10.3.5.5.4. Australia Preimplantation Genetic Testing Market by End User
10.3.5.6. Rest of Asia-Pacific Preimplantation Genetic Testing Market
10.3.5.6.1. Rest of Asia-Pacific Preimplantation Genetic Testing Market by Technology
10.3.5.6.2. Rest of Asia-Pacific Preimplantation Genetic Testing Market by Procedure Type
10.3.5.6.3. Rest of Asia-Pacific Preimplantation Genetic Testing Market by Application
10.3.5.6.4. Rest of Asia-Pacific Preimplantation Genetic Testing Market by End User
10.4. RoW
10.4.1. RoW Preimplantation Genetic Testing Market by Technology
10.4.2. RoW Preimplantation Genetic Testing Market by Procedure Type
10.4.3. RoW Preimplantation Genetic Testing Market by Application
10.4.4. RoW Preimplantation Genetic Testing Market by End User
10.4.5. RoW Preimplantation Genetic Testing Market by Sub-region
10.4.5.1. Latin America Preimplantation Genetic Testing Market
10.4.5.1.1. Latin America Preimplantation Genetic Testing Market by Technology
10.4.5.1.2. Latin America Preimplantation Genetic Testing Market by Procedure Type
10.4.5.1.3. Latin America Preimplantation Genetic Testing Market by Application
10.4.5.1.4. Latin America Preimplantation Genetic Testing Market by End User
10.4.5.2. Middle East Preimplantation Genetic Testing Market
10.4.5.2.1. Middle East Preimplantation Genetic Testing Market by Technology
10.4.5.2.2. Middle East Preimplantation Genetic Testing Market by Procedure Type
10.4.5.2.3. Middle East Preimplantation Genetic Testing Market by Application
10.4.5.2.4. Middle East Preimplantation Genetic Testing Market by End User
10.4.5.3. Africa Preimplantation Genetic Testing Market
10.4.5.3.1. Africa Preimplantation Genetic Testing Market by Technology
10.4.5.3.2. Africa Preimplantation Genetic Testing Market by Procedure Type
10.4.5.3.3. Africa Preimplantation Genetic Testing Market by Application
10.4.5.3.4. Africa Preimplantation Genetic Testing Market by End User

Companies Mentioned

Revvity
Thermo Fisher Scientific Inc
Abbott
Agilent Technologies, Inc.
Oxford Gene Technology IP Limited
Quest Diagnostics Incorporated
Natera, Inc.
A CooperSurgical Fertility Company
Genea Pty Limited
Illumina, Inc.

License	Format	Properties	Price
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€2454EUR$2,500USD£2,051GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7062EUR$7,195USD£5,902GBP